Plasma levels and diagnostic value of catestatin in patients with heart failure.

Lin Liu,Wenhui Ding,Renxu Li,Xiaojin Ye,Jing Zhao,Jie Jiang,Lei Meng,Jie Wang,Songyun Chu,Xiaoning Han,Fen Peng
DOI: https://doi.org/10.1016/j.peptides.2013.05.003
IF: 3.867
2013-01-01
Peptides
Abstract:•Plasma CST levels in patients with moderate to severe heart failure were significantly elevated.•Heart failure patients with ischemic etiology had significantly higher plasma CST levels than those with non-ischemic heart disease.•Plasma CST was not an ideal marker in the diagnosis of moderate to severe HF. Combining CST and BNP did not provide incremental information in the diagnosis.
What problem does this paper attempt to address?